Ülevaade raviturbast ja turbaravist (Review of therapeutic peat and peat therapy)
review Grade C 2013 Language: et
Authors: Übner, Monika
Journal: University of Tartu, Pärnu College — Health Resort Laboratory
Key Findings
- Comprehensive Estonian-language review of therapeutic peat covering composition, mechanisms, applications, and clinical evidence
- Anti-inflammatory effect mediated by sulfoglycolipids lowering IL-1, arachidonic acid, LTB4, PGE-2, and thromboxane
- Peat bioactive substances absorbed through hair follicles and apocrine glands via diffusion
- Peat bath vasodilation exceeds plain water bath — effect persists for hours after treatment
- Humic acid estrogenic activity 5000× estradiol standard in Allen-Doisy test (mice)
- TPP (Tolpa Peat Preparation) registered as immunomodulator drug in Poland — stimulates interferon-α, interferon-γ, TNF-α
- Humic acids are antiviral — block virus attachment to cell surface by occupying positively charged glycoprotein regions
- HA concentration-dependent: 10–80 μg/ml increases TNF-α 3× (pro-inflammatory), >100 μg/ml decreases TNF-α 10× (anti-inflammatory)
- Peat should not be heated above 60°C — above this, HMA concentration increases 2.5× causing receptor desensitization
- Parika bog peat: 59% humic substances, 33% of which are HMA, 7.3% lipids
- Peat therapy indications: acne, rheumatic pain, psoriasis, osteoarthritis, fibromyalgia, stress, skin conditions
- Contraindications for peat bath: high fever, open wounds, heart failure, high blood pressure, diabetes, pregnancy
Comprehensive review by Monika Übner (Health Resort Laboratory, University of Tartu Pärnu College) covering the full scope of therapeutic peat science. Written in Estonian, this review synthesizes European peat therapy literature with Estonian research on Parika peatland peat.
Key Topics Covered
- Peat composition — Humic substances (HA, HMA, FA), lipids, trace elements; quality criteria (H6+ humification, >20% HS, <12% ash)
- Skin effects — Transdermal permeation of bioactives; seborrheic dermatitis treatment (82 patients); skin moisture and lipid improvements
- Humic substances — Detailed biochemistry; FA/HMA agonist activity on α2-adrenergic and D2 dopamine receptors; 4–6 hour duration
- Anti-inflammatory mechanisms — Sulfoglycolipids, cytokine modulation, dose-dependent TNF-α response
- TPP (Tolpa Peat Preparation) — Polish immunomodulator drug; interferon stimulation; antitoxic, antimutagenic properties
- Clinical applications — Peat baths, wraps, sauna protocols; indications and contraindications lists
- Estonian peat — Parika as highest-quality source; ecological purity; heavy metal safety
Significance for Knowledge Graph
This review serves as a secondary source connecting many primary studies already in the graph. Its value lies in the comprehensive contraindications list, the TPP immunomodulator data, and the Estonian-specific Parika peat characterization. The dose-dependent TNF-α finding (Junek et al. 2009) is particularly important for understanding humic acid’s bimodal immune effect.
reviewestoniantherapeutic-peathumic-substancesanti-inflammatoryantiviralestrogenicimmunomodulatoryTPPcontraindicationsbalneotherapy